PEPentwater Capital Management LP
Institutional investor · Portfolio as of Q3 2019
Top Holdings155 positions
| 5.3M | $1.6B | 24.8% | — | — | — | Decreased — | |
CELGENE CORP | 6.2M | $615.4M | 9.6% | — | — | 3 qtrssince 2019-Q1 | Increased 66 |
State Street Spdr S&P 500 Etf | 1.2M | $350.2M | 5.5% | $266.49 | +0.76% | 3 qtrssince 2019-Q1 | Increased 97 |
ZAYO GROUP HOLDINGS INC | 8.4M | $286.3M | 4.5% | — | — | 3 qtrssince 2019-Q1 | Increased 59 |
| 2.5M | $277.8M | 4.3% | — | — | — | Increased — | |
CYPRESS SEMICONDUCTOR CORP | 9.6M | $224.5M | 3.5% | — | — | 2 qtrssince 2019-Q2 | Decreased 0 |
| 1.9M | $208.4M | 3.3% | — | — | — | Decreased — | |
SPARK THERAPEUTICS INC | 2.1M | $204M | 3.2% | — | — | 2 qtrssince 2019-Q2 | Increased 91 |
| 1.9M | $192.6M | 3.0% | — | — | — | Decreased — | |
MELLANOX TECHNOLOGIES LTD | 1.7M | $186.1M | 2.9% | — | — | 3 qtrssince 2019-Q1 | Decreased 0 |
| 1.2M | $178.4M | 2.8% | — | — | — | Unchanged — | |
ADVANCED DISPOSAL SERVICES I | 3.4M | $109.1M | 1.7% | — | — | 2 qtrssince 2019-Q2 | Increased 61 |
WELLCARE HEALTH PLANS INC | 420,000 | $108.9M | 1.7% | — | — | 3 qtrssince 2019-Q1 | Increased 50 |
| 998,000 | $96.8M | 1.5% | — | — | — | Increased — | |
ESPERION THERAPEUTICS INC NE | 2.5M | $90.9M | 1.4% | $40.11 | -5.81% | 3 qtrssince 2019-Q1 | Increased 48 |
PG&E Corp | 8.6M | $85.8M | 1.3% | $14.05 | -28.83% | 3 qtrssince 2019-Q1 | Increased 73 |
| 7.3M | $84.7M | 1.3% | — | — | 3 qtrssince 2019-Q1 | Decreased 0 | |
TURQUOISE HILL RESOURCES LTD | 177.3M | $84.3M | 1.3% | — | — | 3 qtrssince 2019-Q1 | Decreased 0 |
INTELSAT SA | 3.4M | $76.8M | 1.2% | — | — | 2 qtrssince 2019-Q2 | Increased 75 |
| 2.2M | $75.8M | 1.2% | — | — | — | Increased — |
Pentwater Capital Management LP manages $6.4B across 155 positions as of Q3 2019. Top holdings: SPDR S&P 500 ETF TR puts (24.8%), CELG (9.6%), SPY (5.5%). Fund DNA: Momentum Trader. HoldingsIntel Score: 1.5/5.0.
Active quarter - 45 new positions, 59 exits, 15 increased. Top move: SPY (INCREASED, conviction 97). Portfolio: $6.4B across 155 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR